Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-22-001079)

Filing Details

Accession Number:: 0001562180-22-001079
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-03 17:32:14
Reporting Period:: 2022-02-01

Accepted Time:: 2022-02-03 17:32:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1395937	Syndax Pharmaceuticals Inc	SNDX	Pharmaceutical Preparations (2834)	320162505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594274	Peter Ordentlich	C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-01-31	1,412	$12.39	1,412	No	4	J	Direct
Common Stock	Disposition	2022-02-01	1,412	$16.65	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Acquisiton	2022-02-02	80,000	$15.79	80,000	$15.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
80,000		2032-02-02	No	4	A	Direct

Footnotes

The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,412 shares by the Reporting Person on 01/31/2022 pursuant to the Issuer's Employee Stock Purchase Plan.
1/48th of the shares subject to the option shall vest monthly over a four-year period.